Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

NCT06124378 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Colonic Neoplasms
Neoadjuvant Therapy
Immune Checkpoint Inhibitors

Interventions

DRUG: Tislelizumab
DRUG: Oxaliplatin
DRUG: Capecitabine
PROCEDURE: Colectomy

Sponsor

First Affiliated Hospital of Guangxi Medical University